BRAINP Stock Overview
Develops digital therapeutics for Alzheimer’s and dementia. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Brain+ A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | DKK 0.089 |
| 52 Week High | DKK 0.22 |
| 52 Week Low | DKK 0.06 |
| Beta | 0 |
| 1 Month Change | -10.30% |
| 3 Month Change | 11.00% |
| 1 Year Change | -56.47% |
| 3 Year Change | -97.39% |
| 5 Year Change | n/a |
| Change since IPO | -97.98% |
Recent News & Updates
Recent updates
Shareholder Returns
| BRAINP | DK Healthcare Services | DK Market | |
|---|---|---|---|
| 7D | -1.8% | 0.7% | -11.2% |
| 1Y | -56.5% | 11.8% | -4.9% |
Return vs Industry: BRAINP underperformed the Danish Healthcare Services industry which returned 11.8% over the past year.
Return vs Market: BRAINP underperformed the Danish Market which returned -4.9% over the past year.
Price Volatility
| BRAINP volatility | |
|---|---|
| BRAINP Average Weekly Movement | 12.2% |
| Healthcare Services Industry Average Movement | 6.0% |
| Market Average Movement | 4.3% |
| 10% most volatile stocks in DK Market | 10.4% |
| 10% least volatile stocks in DK Market | 2.8% |
Stable Share Price: BRAINP's share price has been volatile over the past 3 months compared to the Danish market.
Volatility Over Time: BRAINP's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of Danish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | n/a | Kim Baden-Kristensen | www.brain-plus.com |
Brain+ A/S develops digital therapeutics for Alzheimer’s and dementia. It develops cognitive stimulation therapy (CST)-Assistant, a health tech solution to support scalable and delivery of group CST via a readily accessible preparation system, content adaptability and a standardized delivery form, which lessens the dependence of CST performance on therapists; CST - Home Care for use to extend and scale the delivery of CST to a home setting, enabling broader access to the therapy for a dementia population at limited costs; CST/ computerized cognitive training (CCT) combination product for individuals with mild cognitive impairment, combining cognitive stimulation therapy with computerized cognitive training to train cognitive function and potentially delay the transition to dementia; and Starry Night, a software based test designed to detect early signs of cognitive decline and enable early targeted intervention and treatment. Brain+ A/S was incorporated in 2012 and is based in Copenhagen, Denmark.
Brain+ A/S Fundamentals Summary
| BRAINP fundamental statistics | |
|---|---|
| Market cap | DKK 18.87m |
| Earnings (TTM) | -DKK 462.19k |
| Revenue (TTM) | DKK 6.08m |
0.0x
P/S Ratio0.0x
P/E RatioIs BRAINP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BRAINP income statement (TTM) | |
|---|---|
| Revenue | DKK 6.08m |
| Cost of Revenue | DKK 0 |
| Gross Profit | DKK 6.08m |
| Other Expenses | DKK 6.55m |
| Earnings | -DKK 462.19k |
Last Reported Earnings
Dec 31, 2018
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did BRAINP perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 19:05 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2018/12/31 |
| Annual Earnings | 2018/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Brain+ A/S is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|